GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Amplia Therapeutics Ltd (OTCPK:INNMF) » Definitions » Cyclically Adjusted PB Ratio

Amplia Therapeutics (Amplia Therapeutics) Cyclically Adjusted PB Ratio : 0.30 (As of Apr. 28, 2024)


View and export this data going back to 2015. Start your Free Trial

What is Amplia Therapeutics Cyclically Adjusted PB Ratio?

As of today (2024-04-28), Amplia Therapeutics's current share price is $0.0505. Amplia Therapeutics's Cyclically Adjusted Book per Share for the fiscal year that ended in Mar23 was $0.17. Amplia Therapeutics's Cyclically Adjusted PB Ratio for today is 0.30.

The historical rank and industry rank for Amplia Therapeutics's Cyclically Adjusted PB Ratio or its related term are showing as below:

INNMF' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 0   Med: 0   Max: 0.37
Current: 0.29

During the past 10 years, Amplia Therapeutics's highest Cyclically Adjusted PB Ratio was 0.37. The lowest was 0.00. And the median was 0.00.

INNMF's Cyclically Adjusted PB Ratio is ranked better than
79.72% of 641 companies
in the Biotechnology industry
Industry Median: 1.72 vs INNMF: 0.29

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Amplia Therapeutics's adjusted book value per share data of for the fiscal year that ended in Mar23 was $0.053. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $0.17 for the trailing ten years ended in Mar23.

Shiller PE for Stocks: The True Measure of Stock Valuation


Amplia Therapeutics Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Amplia Therapeutics's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Amplia Therapeutics Cyclically Adjusted PB Ratio Chart

Amplia Therapeutics Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 0.37

Amplia Therapeutics Semi-Annual Data
Mar14 Sep14 Mar15 Sep15 Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - 0.37 -

Competitive Comparison of Amplia Therapeutics's Cyclically Adjusted PB Ratio

For the Biotechnology subindustry, Amplia Therapeutics's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Amplia Therapeutics's Cyclically Adjusted PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Amplia Therapeutics's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Amplia Therapeutics's Cyclically Adjusted PB Ratio falls into.



Amplia Therapeutics Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Amplia Therapeutics's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=0.0505/0.17
=0.30

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Amplia Therapeutics's Cyclically Adjusted Book per Share for the fiscal year that ended in Mar23 is calculated as:

For example, Amplia Therapeutics's adjusted Book Value per Share data for the fiscal year that ended in Mar23 was:

Adj_Book=Book Value per Share/CPI of Mar23 (Change)*Current CPI (Mar23)
=0.053/123.1484*123.1484
=0.053

Current CPI (Mar23) = 123.1484.

Amplia Therapeutics Annual Data

Book Value per Share CPI Adj_Book
201403 0.453 97.887 0.570
201503 0.191 99.187 0.237
201603 0.134 100.488 0.164
201703 0.199 102.624 0.239
201803 0.072 104.574 0.085
201903 0.133 105.967 0.155
202003 0.072 108.289 0.082
202103 0.071 109.496 0.080
202203 0.081 115.069 0.087
202303 0.053 123.148 0.053

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Amplia Therapeutics  (OTCPK:INNMF) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Amplia Therapeutics Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Amplia Therapeutics's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Amplia Therapeutics (Amplia Therapeutics) Business Description

Traded in Other Exchanges
Address
350 Queen Street, Level 17, Melbourne, VIC, AUS, 3000
Amplia Therapeutics Ltd is an Australian pharmaceutical company advancing a pipeline of Focal Adhesion Kinase (FAK) inhibitors for cancer and fibrosis. Its molecule, AMP945 is a pure-play inhibitor, while the second molecule, AMP886, is a multi-action molecule that hits two other important cancer pathways - VEGFR3 and FLT3.

Amplia Therapeutics (Amplia Therapeutics) Headlines